235 related articles for article (PubMed ID: 19798624)
1. [New therapeutic approaches in the treatment of retinopathy of prematurity].
Jandeck C
Klin Monbl Augenheilkd; 2009 Nov; 226(11):914-20. PubMed ID: 19798624
[TBL] [Abstract][Full Text] [Related]
2. [Retinopathy of prematurity].
Jandeck C; Kellner U; Foerster MH
Klin Monbl Augenheilkd; 2004 Mar; 221(3):147-59. PubMed ID: 15052520
[TBL] [Abstract][Full Text] [Related]
3. [VEGF antibodies as therapy for retinopathy of prematurity].
Oberacher-Velten IM; Helbig H
Klin Monbl Augenheilkd; 2010 Sep; 227(9):694-700. PubMed ID: 20845249
[TBL] [Abstract][Full Text] [Related]
4. Time to consider a new treatment protocol for aggressive posterior retinopathy of prematurity?
Spandau U; Tomic Z; Ewald U; Larsson E; Akerblom H; Holmström G
Acta Ophthalmol; 2013 Mar; 91(2):170-5. PubMed ID: 22268644
[TBL] [Abstract][Full Text] [Related]
5. Effects of intravitreal bevacizumab and laser in retinopathy of prematurity therapy on the development of peripheral retinal vessels.
Lee JY; Chae JB; Yang SJ; Yoon YH; Kim JG
Graefes Arch Clin Exp Ophthalmol; 2010 Sep; 248(9):1257-62. PubMed ID: 20393741
[TBL] [Abstract][Full Text] [Related]
6. Retinopathy of prematurity.
Jordan CO
Pediatr Clin North Am; 2014 Jun; 61(3):567-77. PubMed ID: 24852153
[TBL] [Abstract][Full Text] [Related]
7. Reactivation of retinopathy of prematurity after ranibizumab treatment.
Wong RK; Hubschman S; Tsui I
Retina; 2015 Apr; 35(4):675-80. PubMed ID: 25768252
[TBL] [Abstract][Full Text] [Related]
8. An updated study of the use of bevacizumab in the treatment of patients with prethreshold retinopathy of prematurity in taiwan.
Wu WC; Kuo HK; Yeh PT; Yang CM; Lai CC; Chen SN
Am J Ophthalmol; 2013 Jan; 155(1):150-158.e1. PubMed ID: 22967867
[TBL] [Abstract][Full Text] [Related]
9. Effects and complications of bevacizumab use in patients with retinopathy of prematurity: a multicenter study in taiwan.
Wu WC; Yeh PT; Chen SN; Yang CM; Lai CC; Kuo HK
Ophthalmology; 2011 Jan; 118(1):176-83. PubMed ID: 20673589
[TBL] [Abstract][Full Text] [Related]
10. Current and future trends in treatment of severe retinopathy of prematurity.
Wallace DK; Wu KY
Clin Perinatol; 2013 Jun; 40(2):297-310. PubMed ID: 23719311
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal bevacizumab following laser therapy for severe retinopathy of prematurity.
Erol N; Gürsoy H; Sahin A; Basmak H
J Pediatr Ophthalmol Strabismus; 2010 Aug; 47 Online():e1-4. PubMed ID: 21158371
[TBL] [Abstract][Full Text] [Related]
12. Management of retinopathy of prematurity.
Fleck BW
Arch Dis Child Fetal Neonatal Ed; 2013 Sep; 98(5):F454-6. PubMed ID: 23813885
[TBL] [Abstract][Full Text] [Related]
13. [Retinopathy of prematurity - therapy. Part 2].
Prepiaková Z; Tomčíková D; Kostolná B; Gerinec A
Cesk Slov Oftalmol; 2014 Apr; 70(2):50-4. PubMed ID: 25030312
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor antagonist therapy for retinopathy of prematurity.
Hartnett ME
Clin Perinatol; 2014 Dec; 41(4):925-43. PubMed ID: 25459781
[TBL] [Abstract][Full Text] [Related]
15. Vitreous levels of erythropoietin and vascular endothelial growth factor in eyes with retinopathy of prematurity.
Sato T; Kusaka S; Shimojo H; Fujikado T
Ophthalmology; 2009 Sep; 116(9):1599-603. PubMed ID: 19371954
[TBL] [Abstract][Full Text] [Related]
16. Incidence and result of treatment-demanding retinopathy of prematurity using revised U.S. screening guidelines.
Kuo HK; Chen CC; Chen YH; Huang HC; Liu CA; Chen FS; Chung MY
Am J Perinatol; 2012 Nov; 29(10):827-31. PubMed ID: 22773294
[TBL] [Abstract][Full Text] [Related]
17. An evidence-based meta-analysis of vascular endothelial growth factor inhibition in pediatric retinal diseases: part 1. Retinopathy of prematurity.
Mititelu M; Chaudhary KM; Lieberman RM
J Pediatr Ophthalmol Strabismus; 2012; 49(6):332-40. PubMed ID: 22938516
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology, screening and treatment of ROP: A multi-disciplinary perspective.
Chan-Ling T; Gole GA; Quinn GE; Adamson SJ; Darlow BA
Prog Retin Eye Res; 2018 Jan; 62():77-119. PubMed ID: 28958885
[TBL] [Abstract][Full Text] [Related]
19. Treatment of type 1 retinopathy of prematurity with intravitreal bevacizumab (Avastin).
Dorta P; Kychenthal A
Retina; 2010 Apr; 30(4 Suppl):S24-31. PubMed ID: 20224475
[TBL] [Abstract][Full Text] [Related]
20. [Retinopathy of prematurity: clinical findings and current opinions on diagnosis and treatment].
Modrzejewska M
Ann Acad Med Stetin; 2006; 52(1):73-8; discussion 78. PubMed ID: 17131850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
